Navigation Links
SightLine Health Adds Naviscan PEM Technology to Breast Cancer Treatment Services
Date:10/4/2010

SAN DIEGO, Oct. 4 /PRNewswire/ -- To mark the beginning of Breast Cancer Awareness Month, SightLine Health has expanded its breast cancer treatment services at its West Houston facility to include the Naviscan PEM scanner.  PEM (Positron Emission Mammography) scanners are high-resolution breast PET systems that show the location as well as the metabolic phase of a lesion.  The metabolic view allows physicians to make the optimal cancer care decision by providing an unprecedented ability to distinguish between benign and malignant lesions, what researchers term "specificity."

SightLine Health, which opened a third center in Houston earlier this year, has constantly invested in innovative technologies in the battle to cure breast cancer.  It is staffed by a group of accredited professionals and offers comprehensive care to patients and their families through the entire treatment process. "Adding a cutting edge molecular breast imaging tool, such as PEM, will benefit breast cancer patients by providing a more streamlined approach to their care," said Dr. Stephen Rose, the breast radiologist who will be interpreting the PEM scans.

Results from an NIH-sponsored clinical study [NIH Grant 5R44CA103102], recently presented at the 2010 Society of Nuclear Medicine Annual Meeting, comparing PEM and breast MRI demonstrate PEM's clinical appropriateness.  The multi-site study of hundreds of women with newly diagnosed breast cancer shows that PEM demonstrated comparably high sensitivity but a six percent improvement in specificity, ability to differentiate between malignant and benign lesions, suggesting that PEM may reduce unnecessary biopsies. These results are particularly significant for women who cannot tolerate an MRI exam and require an alternate imaging tool. The study is slated for publication in the December issue of the journal Radiology.

"Naviscan is pleased to be the first imaging modality ever adopted by SightLine Health.  We believe that PEM will help differentiate their breast cancer treatment services and help referring breast surgeons better plan their surgeries," said Paul J. Mirabella, Chairman and CEO, Naviscan, Inc.

About SightLine Health

SightLine Health, headquartered in Houston, Texas, specializes in groundbreaking procedures such as Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT) and High Dose Rate (HDR) brachytherapy for cancer. The company began operations in 2005 when it opened its first facility near the renowned Texas Medical Center.  

About Naviscan, Inc.

Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PEM scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain FDA-clearance for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance. For more information, call 1.858.587.3641 or visit www.naviscan.com.


'/>"/>
SOURCE Naviscan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MyVirtualHealthCheck.com: The First No-Cost Personal Health & Disease Management System
2. Delta Health Technologies ClinicalVirtuoso™ Targets Homecare Therapists
3. Advanced Life Sciences Offers Testimony at Senate Hearing on Defending Against Public Health Threats
4. Innovations to Omron Healthcare Home Blood Pressure Monitors Provide New Solutions for Consumers
5. United American Healthcare Corporation Announces Results of Annual Meeting of Shareholders
6. Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinsons Disease
7. Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season
8. HART Health: Headaches Cause More Than $61 Billion a Year in Lost Time
9. Prevent Blindness America Issues Call-to-Action to Make UV Eye Protection a National Health Priority
10. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
11. Wound Management Technologies, Inc. Furthers its Government Initiatives and Business Development within the Veterans Health Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology:
(Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare ... Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , ... medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. ...
Breaking Medicine News(10 mins):